Catalyst Wire Dossier Catalyst Wire Dossier

Zuberitamab

Zuberitamab
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Zuberitamab, covering 2025-01-03 to 2025-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Zuberitamab for EBV Infection Post-Allo-HSCT [Phase 2]

See pricing